Cormedix Inc (STU:19KA)
€ 9.65 0.25 (2.66%) Market Cap: 601.04 Mil Enterprise Value: 558.66 Mil PE Ratio: 0 PB Ratio: 10.17 GF Score: 52/100

CorMedix Inc. - Special Call Transcript

May 19, 2020 / 04:00PM GMT
Release Date Price: €3.76 (+1.62%)
Operator

Greetings, and welcome to antimicrobial resistance, catheter-related blood stream infections and the potential for Neutrolin, hosted by CorMedix conference call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Dr. Paul Chew, Chief Medical Officer from CorMedix. Mr. Chew, you may begin.

Paul Chew
CorMedix Inc. - Acting Chief Medical Officer

Good morning, and good afternoon, everyone. Welcome to the CorMedix webinar antimicrobial resistance, catheter-related bloodstream infections and the potential for Neutrolin. Please read the forward-looking statement slide when you have a chance.

COVID-19 is a global pandemic that's focusing everyone on the need for disease prevention, but there's a group, a vulnerable group, that faces life-threatening infection every day. Patients with chronic hemodialysis catheters face the risk of catheter infection, hospitalization and even premature death from sepsis and its complications.

On this slide, the National Health

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot